Data Set available for Liquid Biopsy of CML Diagnosis

Chronic Myeloid Leukemia, CML, is caused in patients with myeloproliferative disorders by the presence of BCR::ABL1.  The research discussed the integration of microfluidic chips with biosensors for the purpose of detecting biomarkers in peripheral blood thereby showing the raw experimental data set avaialble, liquid bipsy sample set available and Calculation for methods and data Simulation along with graphs, which could obviate the need for painful biopsies, thereby improving diagnostic accuracy and accessibility.